A $17.4M seed round has landed for iPremom, a medical FemTech startup focused on catching gestational diseases early. The company is building molecular tests aimed at diagnosing conditions like preeclampsia before they escalate, translating existing scientific research into practical screening tools.
The funding gives iPremom runway to advance its diagnostic pipeline, though specifics on how the capital will be deployed were not disclosed. The round’s size, notable for a seed-stage company in the women’s health space, signals growing investor appetite for tools that address pregnancy-related risks-an area that has historically seen less venture attention than other medtech niches.





.png&w=3840&q=75)












